BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9636453)

  • 1. Posttransplant lymphoproliferative disorders in cardiac transplant patients.
    Fatio R; Sütsch G; Mayer K; Follath F; Corti R; Gallino A; Kiowski W
    Transplant Proc; 1998 Jun; 30(4):1118-20. PubMed ID: 9636453
    [No Abstract]   [Full Text] [Related]  

  • 2. Low incidence of malignancy in heart-transplant recipients in Taiwan: an update and comparison with kidney-transplant recipients.
    Hsu RB; Chang CI; Tsai MK; Lee PH; Chou NK; Chi NH; Wang SS; Chu SH
    Eur J Cardiothorac Surg; 2010 May; 37(5):1117-21. PubMed ID: 20045346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transplant lymphoproliferative disease is associated with early sternotomy and left ventricular hypoplasia during infancy: a population-based retrospective review.
    Ekman-Joelsson BM; Wåhlander H; Synnergren M; Sager M; Mellgren K
    Cardiol Young; 2017 Nov; 27(9):1823-1831. PubMed ID: 28780922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors.
    Kumarasinghe G; Lavee O; Parker A; Nivison-Smith I; Milliken S; Dodds A; Joseph J; Fay K; Ma DD; Malouf M; Plit M; Havryk A; Keogh AM; Hayward CS; Kotlyar E; Jabbour A; Glanville AR; Macdonald PS; Moore JJ
    J Heart Lung Transplant; 2015 Nov; 34(11):1406-14. PubMed ID: 26279197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and pathogenesis of posttransplant lymphoproliferative disorders.
    Ho M
    Transplant Proc; 1995 Oct; 27(5 Suppl 1):38-40. PubMed ID: 7482816
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of lymphoproliferative disorders after cardiac transplantation.
    Chen JM; Barr ML; Chadburn A; Frizzera G; Schenkel FA; Sciacca RR; Reison DS; Addonizio LJ; Rose EA; Knowles DM
    Ann Thorac Surg; 1993 Sep; 56(3):527-38. PubMed ID: 8379727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplant lymphoproliferative disorders and other malignancies after pediatric intestinal transplantation: incidence, clinical features and outcome.
    Ramos E; Hernández F; Andres A; Martínez-Ojinaga E; Molina M; Sarría J; Lopez-Santamaria M; Prieto G
    Pediatr Transplant; 2013 Aug; 17(5):472-8. PubMed ID: 23730927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S; Zafar MN; Best J; Reddy HK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.
    Swinnen LJ; Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson MR; Heroux AL; Dizikes GJ; Pifarre R; Fisher RI
    N Engl J Med; 1990 Dec; 323(25):1723-8. PubMed ID: 2100991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttransplant lymphoproliferative disease presenting as sudden respiratory arrest in a three-year-old child.
    Hague K; Catalano P; Rothschild M; Strauchen J; Fyfe B
    Ann Otol Rhinol Laryngol; 1997 Mar; 106(3):244-7. PubMed ID: 9078939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-transplant lymphoproliferative disorders in renal transplantation: two decades of experience].
    Franco A; Jiménez L; Sillero C; Trigueros M; González D; Alcaraz E; Olivares J
    Nefrologia; 2010; 30(6):669-75. PubMed ID: 21113217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder.
    Preiksaitis JK; Diaz-Mitoma F; Mirzayans F; Roberts S; Tyrrell DL
    J Infect Dis; 1992 Nov; 166(5):986-94. PubMed ID: 1328412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, management, and outcome of posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
    Molmenti EP; Nagata D; Roden J; Squires R; Molmenti H; Casey D; Fasola C; Lopez MJ; Winick N; McPhail W; D'Amico L; Goldstein R; Levy M; Fasola C; Andersen J; Klintmalm G
    Transplant Proc; 2001; 33(1-2):1727. PubMed ID: 11267487
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphoproliferative disorders after heart transplantation.
    Moyer P
    Lancet Oncol; 2006 Mar; 7(3):202. PubMed ID: 16538788
    [No Abstract]   [Full Text] [Related]  

  • 17. Posttransplant lymphoproliferative disorders in transplant recipients.
    Timurağaoğlu A; Uğur-Bilgin A; Colak D; Tuncer M; Gölbaşi I; Hazar V; Kiliçarsłan B; Undar L; Demirbaş A
    Transplant Proc; 2006 Mar; 38(2):641-5. PubMed ID: 16549195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry.
    Aull MJ; Buell JF; Trofe J; First MR; Alloway RR; Hanaway MJ; Wagoner L; Gross TG; Beebe T; Woodle ES
    Transplantation; 2004 Dec; 78(11):1676-82. PubMed ID: 15591959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
    Mendoza F; Kunitake H; Laks H; Odim J
    Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low incidence of posttransplant lymphoproliferative disease in children treated with low-dose immunosuppression after liver transplantation.
    Ganschow R; Schulz T; Meyer T; Broering DC; Burdelski M
    Transplant Proc; 2002 Aug; 34(5):1961-2. PubMed ID: 12176645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.